tradingkey.logo
tradingkey.logo
Search

Sanara Medtech Inc

SMTI
Add to Watchlist
33.860USD
-0.200-0.59%
Close 07-31 16:00ETQuotes delayed by 15 min
311.28MMarket Cap
LossP/E TTM

Sanara Medtech Inc

33.860
-0.200-0.59%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.59%

5 Days

+32.47%

1 Month

+36.31%

6 Months

+53.56%

Year to Date

+45.01%

1 Year

+40.15%

Key Figures
33.620Open
34.000High
576.55KVolume
LossP/E TTM
45.86P/E Dynamic
--Dividend TTM
6.29%Turnover Ratio
34.060Prev. Close
33.620Low
12.56MTurnover
LossP/E Static
44.15P/B
0.00%Div Yield TTM
0.75%ROA
35.95052wk High
0.67Volume Ratio
-9.66MNet Profit
9.17MShares
-3.8918EPS TTM
1.22Beta
2.89%ROE
16.04752wk Low
1.12%Amplitude
90.97%Gross Margin
311.28MMarket Cap
9.96Reward/Risk
3.55%Risk Rate

TradingKey Stock Score of Sanara Medtech Inc

Currency: USD Updated: 2026-07-31

Key Insights

Sanara Medtech Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 73 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 34.33.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sanara Medtech Inc's Score

Industry at a Glance

Industry Ranking
73 / 155
Overall Ranking
152 / 4281
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sanara Medtech Inc Highlights

StrengthsRisks
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 58.67% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 103.12M.
Overvalued
The company’s latest PE is -8.70, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.42M shares, decreasing 29.68% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 7.59K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.81.

Analyst Rating

Based on 3 analysts
Hold
Current Rating
35.000
Target Price
+3.37%
Upside Space

Sanara Medtech Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 3 analysts
Hold
Current Rating
35.000
Target Price
+3.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Sanara Medtech Inc
SMTI
3
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32

Indicators

Indicators
Sell(1)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
1.754
Buy
RSI(14)
83.032
Overbought
STOCH(KDJ)(9,3,3)
94.031
Overbought
ATR(14)
1.530
Low Volatility
CCI(14)
197.755
Buy
Williams %R
3.467
Overbought
TRIX(12,20)
0.901
Sell
StochRSI(14)
93.976
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
30.132
Buy
MA10
27.776
Buy
MA20
26.143
Buy
MA50
24.057
Buy
MA100
21.490
Buy
MA200
22.418
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sanara Medtech Inc Info

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Ticker SymbolSMTI
CompanySanara Medtech Inc
CEOMuppalla (Suresh V)
Websitehttps://sanaramedtech.com/

Shareholders

Shareholders
Shareholders
Proportion
FA Sanara, L.L.C.
38.32%
Tall Pines Capital LLC
5.60%
Howell (Solomon Oden Jr)
5.35%
BlackRock Institutional Trust Company, N.A.
1.85%
Vanguard Capital Management, LLC
1.65%
Other
47.23%

FAQs

What is the current price of Sanara Medtech Inc (SMTI)?

The current price of Sanara Medtech Inc (SMTI) is 33.86.

What is the symbol of Sanara Medtech Inc?

The ticker symbol of Sanara Medtech Inc is SMTI.

What is the 52-week high of Sanara Medtech Inc?

The 52-week high of Sanara Medtech Inc is 35.95.

What is the 52-week low of Sanara Medtech Inc?

The 52-week low of Sanara Medtech Inc is 16.05.

What is the market capitalization of Sanara Medtech Inc?

The market capitalization of Sanara Medtech Inc is 311.28M.

Is Sanara Medtech Inc (SMTI) currently rated as Buy, Hold, or Sell?

According to analysts, Sanara Medtech Inc (SMTI) has an overall rating of signal_hold, with a price target of 35.00.

What is the Earnings Per Share (EPS TTM) of Sanara Medtech Inc (SMTI)?

The Earnings Per Share (EPS TTM) of Sanara Medtech Inc (SMTI) is -4.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.